Log In
Print
BCIQ
Print
Print this Print this
 

oxycodone/acetaminophen (Xartemis XR) (COV795) (formerly MNK-795)

  Manage Alerts
Collapse Summary General Information
Company Mallinckrodt plc
DescriptionControlled-release oral formulation of oxycodone and acetaminophen formulated using Depomed's AcuForm gastric retentive formulation technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationPain
Indication DetailsManage moderate to severe acute pain where the use of an opioid analgesic is appropriate
Regulatory Designation

U.S. - Priority Review (Manage moderate to severe acute pain where the use of an opioid analgesic is appropriate)

Partner

Depomed Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today